- Home
- FRO vs HAE Comparison
FRO vs HAE Comparison
Compare FRO & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRO
- HAE
- Stock Information
- Founded
- FRO 1985
- HAE 1971
- Country
- FRO Cyprus
- HAE United States
- Employees
- FRO N/A
- HAE N/A
- Industry
- FRO Marine Transportation
- HAE Medical/Dental Instruments
- Sector
- FRO Consumer Discretionary
- HAE Health Care
- Exchange
- FRO Nasdaq
- HAE Nasdaq
- Market Cap
- FRO 4.0B
- HAE 3.3B
- IPO Year
- FRO N/A
- HAE 1991
- Fundamental
- Price
- FRO $18.33
- HAE $72.56
- Analyst Decision
- FRO Strong Buy
- HAE Strong Buy
- Analyst Count
- FRO 3
- HAE 10
- Target Price
- FRO $23.33
- HAE $99.00
- AVG Volume (30 Days)
- FRO 2.6M
- HAE 570.6K
- Earning Date
- FRO 08-29-2025
- HAE 08-07-2025
- Dividend Yield
- FRO 9.71%
- HAE N/A
- EPS Growth
- FRO N/A
- HAE 44.54
- EPS
- FRO 1.56
- HAE 3.31
- Revenue
- FRO $1,899,854,000.00
- HAE $1,360,824,000.00
- Revenue This Year
- FRO N/A
- HAE N/A
- Revenue Next Year
- FRO $14.38
- HAE $7.26
- P/E Ratio
- FRO $11.78
- HAE $21.85
- Revenue Growth
- FRO 0.88
- HAE 3.96
- 52 Week Low
- FRO $12.40
- HAE $55.30
- 52 Week High
- FRO $25.68
- HAE $94.99
- Technical
- Relative Strength Index (RSI)
- FRO 52.49
- HAE 46.26
- Support Level
- FRO $18.04
- HAE $74.45
- Resistance Level
- FRO $19.13
- HAE $76.83
- Average True Range (ATR)
- FRO 0.47
- HAE 2.08
- MACD
- FRO 0.05
- HAE -0.60
- Stochastic Oscillator
- FRO 72.22
- HAE 6.35
About FRO Frontline Plc
Frontline PLC is an international shipping company engaged in the seaborne transportation of crude oil and oil products. Group operates through the tankers segment. The tankers segment includes crude oil tankers and product tankers. Its geographical area of operation includes Arabian Gulf, West African, the North Sea, and the Caribbean. Frontline earns revenue through voyage charters, time charters, and a finance lease. It is also involved in the charter, purchase, and sale of vessels.
About HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.